These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 16772755

  • 1. Preclinical evidence of neuroprotection by cholinesterase inhibitors.
    Akaike A.
    Alzheimer Dis Assoc Disord; 2006; 20(2 Suppl 1):S8-11. PubMed ID: 16772755
    [Abstract] [Full Text] [Related]

  • 2. Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons.
    Takada Y, Yonezawa A, Kume T, Katsuki H, Kaneko S, Sugimoto H, Akaike A.
    J Pharmacol Exp Ther; 2003 Aug; 306(2):772-7. PubMed ID: 12734391
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of neuroprotection by donepezil pretreatment in rat cortical neurons chronically treated with donepezil.
    Takada-Takatori Y, Kume T, Ohgi Y, Izumi Y, Niidome T, Fujii T, Sugimoto H, Akaike A.
    J Neurosci Res; 2008 Dec; 86(16):3575-83. PubMed ID: 18655200
    [Abstract] [Full Text] [Related]

  • 4. Up-regulation of nicotinic acetylcholine receptors by central-type acetylcholinesterase inhibitors in rat cortical neurons.
    Kume T, Sugimoto M, Takada Y, Yamaguchi T, Yonezawa A, Katsuki H, Sugimoto H, Akaike A.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):77-85. PubMed ID: 16313899
    [Abstract] [Full Text] [Related]

  • 5. Donepezil attenuates excitotoxic damage induced by membrane depolarization of cortical neurons exposed to veratridine.
    Akasofu S, Sawada K, Kosasa T, Hihara H, Ogura H, Akaike A.
    Eur J Pharmacol; 2008 Jul 07; 588(2-3):189-97. PubMed ID: 18508044
    [Abstract] [Full Text] [Related]

  • 6. Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade.
    Takada-Takatori Y, Kume T, Sugimoto M, Katsuki H, Sugimoto H, Akaike A.
    Neuropharmacology; 2006 Sep 07; 51(3):474-86. PubMed ID: 16762377
    [Abstract] [Full Text] [Related]

  • 7. Protective effect of donepezil against Abeta(1-40) neurotoxicity in rat septal neurons.
    Kimura M, Akasofu S, Ogura H, Sawada K.
    Brain Res; 2005 Jun 14; 1047(1):72-84. PubMed ID: 15893738
    [Abstract] [Full Text] [Related]

  • 8. [Mechanisms of neuroprotective effects of therapeutic acetylcholinesterase inhibitors used in treatment of Alzheimer's disease].
    Takatori Y.
    Yakugaku Zasshi; 2006 Aug 14; 126(8):607-16. PubMed ID: 16880719
    [Abstract] [Full Text] [Related]

  • 9. Protective effect of donepezil in primary-cultured rat cortical neurons exposed to N-methyl-d-aspartate (NMDA) toxicity.
    Akasofu S, Kimura M, Kosasa T, Ogura H, Sawada K.
    Eur J Pharmacol; 2006 Jan 20; 530(3):215-22. PubMed ID: 16406045
    [Abstract] [Full Text] [Related]

  • 10. Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-beta-induced neuronal cell death.
    Noh MY, Koh SH, Kim Y, Kim HY, Cho GW, Kim SH.
    J Neurochem; 2009 Mar 20; 108(5):1116-25. PubMed ID: 19077054
    [Abstract] [Full Text] [Related]

  • 11. Galantamine modulates nicotinic receptor and blocks Abeta-enhanced glutamate toxicity.
    Kihara T, Sawada H, Nakamizo T, Kanki R, Yamashita H, Maelicke A, Shimohama S.
    Biochem Biophys Res Commun; 2004 Dec 17; 325(3):976-82. PubMed ID: 15541385
    [Abstract] [Full Text] [Related]

  • 12. Roles of nicotinic receptors in acetylcholinesterase inhibitor-induced neuroprotection and nicotinic receptor up-regulation.
    Takada-Takatori Y, Kume T, Izumi Y, Ohgi Y, Niidome T, Fujii T, Sugimoto H, Akaike A.
    Biol Pharm Bull; 2009 Mar 17; 32(3):318-24. PubMed ID: 19252271
    [Abstract] [Full Text] [Related]

  • 13. Comparison of donepezil and memantine for protective effect against amyloid-beta(1-42) toxicity in rat septal neurons.
    Kimura M, Komatsu H, Ogura H, Sawada K.
    Neurosci Lett; 2005 Dec 31; 391(1-2):17-21. PubMed ID: 16154269
    [Abstract] [Full Text] [Related]

  • 14. Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against beta-amyloid toxicity.
    Caraci F, Chisari M, Frasca G, Canonico PL, Battaglia A, Calafiore M, Battaglia G, Bosco P, Nicoletti F, Copani A, Sortino MA.
    Brain Res; 2005 Jun 14; 1047(1):30-7. PubMed ID: 15882840
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease.
    Nordberg A.
    Alzheimer Dis Assoc Disord; 2006 Jun 14; 20(2 Suppl 1):S12-8. PubMed ID: 16772751
    [Abstract] [Full Text] [Related]

  • 16. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity.
    Kihara T, Shimohama S, Sawada H, Kimura J, Kume T, Kochiyama H, Maeda T, Akaike A.
    Ann Neurol; 1997 Aug 14; 42(2):159-63. PubMed ID: 9266724
    [Abstract] [Full Text] [Related]

  • 17. Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons.
    Melo JB, Sousa C, Garção P, Oliveira CR, Agostinho P.
    Eur J Neurosci; 2009 Feb 14; 29(3):455-64. PubMed ID: 19222556
    [Abstract] [Full Text] [Related]

  • 18. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.
    Arias E, Gallego-Sandín S, Villarroya M, García AG, López MG.
    J Pharmacol Exp Ther; 2005 Dec 14; 315(3):1346-53. PubMed ID: 16144975
    [Abstract] [Full Text] [Related]

  • 19. Neuroprotective effects of galanthamine and tacrine against glutamate neurotoxicity.
    Takada-Takatori Y, Kume T, Sugimoto M, Katsuki H, Niidome T, Sugimoto H, Fujii T, Okabe S, Akaike A.
    Eur J Pharmacol; 2006 Nov 07; 549(1-3):19-26. PubMed ID: 16996497
    [Abstract] [Full Text] [Related]

  • 20. Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats.
    Liang YQ, Tang XC.
    Neurosci Lett; 2004 May 06; 361(1-3):56-9. PubMed ID: 15135892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.